Genome-wide association interaction analysis for Alzheimer's disease

[1]  M. Hart,et al.  Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease , 2013, Journal of neurochemistry.

[2]  Christine Van Broeckhoven,et al.  Genetic insights in Alzheimer's disease , 2013, The Lancet Neurology.

[3]  G. Wistow.  The human crystallin gene families , 2012, Human Genomics.

[4]  Margaret A. Pericak-Vance,et al.  Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants , 2012, PLoS genetics.

[5]  R. Loewith,et al.  Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis , 2012, Nature Cell Biology.

[6]  Asha A. Nair,et al.  Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications , 2012, Molecular Neurodegeneration.

[7]  Elena S. Gusareva,et al.  Lower-Order Effects Adjustment in Quantitative Traits Model-Based Multifactor Dimensionality Reduction , 2012, PloS one.

[8]  Kristel Van Steen,et al.  Travelling the world of gene-gene interactions , 2012, Briefings Bioinform..

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[10]  M. L. Calle,et al.  Model‐Based Multifactor Dimensionality Reduction for detecting epistasis in case–control data in the presence of noise , 2011, Annals of human genetics.

[11]  K. Sleegers,et al.  Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. , 2010, Journal of Alzheimer's disease : JAD.

[12]  Qiang Yang,et al.  BOOST: A fast approach to detecting gene-gene interactions in genome-wide case-control studies , 2010, American journal of human genetics.

[13]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[14]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[15]  Bernhard Horsthemke,et al.  Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24 , 2009, Nature Genetics.

[16]  Dimitris Anastassiou,et al.  Synergy Disequilibrium Plots: graphical visualization of pairwise synergies and redundancies of SNPs with respect to a phenotype , 2009, Bioinform..

[17]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[18]  Thomas W. Mühleisen,et al.  Susceptibility variants for male-pattern baldness on chromosome 20p11 , 2008, Nature Genetics.

[19]  P. Phillips.  Epistasis — the essential role of gene interactions in the structure and evolution of genetic systems , 2008, Nature Reviews Genetics.

[20]  R. C. Dickson.  New insights into sphingolipid metabolism and function in budding yeast , 2008 .

[21]  D. Anastassiou.  Computational analysis of the synergy among multiple interacting genes , 2007, Molecular systems biology.

[22]  Jiang Gui,et al.  Symbolic Modeling of Epistasis , 2007, Human Heredity.

[23]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005 .

[24]  Jason H. Moore,et al.  A global view of epistasis , 2005, Nature Genetics.

[25]  G. Molenberghs,et al.  Multicollinearity in prognostic factor analyses using the EORTC QLQ‐C30: identification and impact on model selection , 2002, Statistics in medicine.

[26]  B. Winblad,et al.  Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients , 2000, Neuroscience Letters.

[27]  B. Winblad,et al.  Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. , 2000, Neuroscience Letters.